Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies

Código QR

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies

Understanding of the molecular mechanisms of prostate cancer has led to development of therapeutic strategies targeting androgen receptor (AR). These androgen-receptor signaling inhibitors (ARSI) include androgen synthesis inhibitor-abiraterone and androgen receptor antagonists-enzalutamide, apaluta...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Aasems Jacob, Rishi Raj, Derek B. Allison, Zin W. Myint
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	prostate cancer castrate-resistant growth metastases androgen receptor glucocorticoid receptor cytokines Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/be6b500cf3f34a71965605d8b1c7087c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Effect of Concurrent Training and Supplementation with β-Hydroxy- β-Methylbutyirate (HMB) on the Prostate: Alterations in the Androgen Receptor and Inflammation
por: Baptista,Danilo Bianchini, et al.
Publicado: (2018)

Interaction between Non-Coding RNAs and Androgen Receptor with an Especial Focus on Prostate Cancer
por: Mohammad Taheri, et al.
Publicado: (2021)

MODERN APPROACH TO MOLECULAR CHARACTERIZATION OF PROSTATE TUMORS
por: E. P. Khvostova, et al.
Publicado: (2012)

Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity
por: Fernando López-Campos, et al.
Publicado: (2021)

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth
por: Joanna L Gillis, et al.
Publicado: (2021)

Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1
por: Zhang Y, et al.
Publicado: (2021)

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Huan Xu, et al.
Publicado: (2021)

Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions
por: Caffo O, et al.
Publicado: (2016)

Stem Cells and Androgen Receptor in Human Periapical Periodontitis
por: Rodríguez,H, et al.
Publicado: (2011)

Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
por: Nikolai A. Ognerubov
Publicado: (2021)

Critical appraisal of cabazitaxel in the management of advanced prostate cancer
por: Sumanta Kumar Pal, et al.
Publicado: (2010)

Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
por: Toru Hanamura, et al.
Publicado: (2021)

A phase II pilot trial investigating the efficacy and activity of single agent granulocyte macrophage colony-stimulating factor as maintenance approach in castration - resistant prostate cancer patients responding to chemotherapy
por: Chadi Nabhan, et al.
Publicado: (2011)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
por: Faiza Naseer, et al.
Publicado: (2021)

An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer
por: Josephina P. M. Vrouwe, et al.
Publicado: (2021)

3-<i>O</i>-Carbamoyl-5,7,20-<i>O</i>-trimethylsilybins: Synthesis and Preliminary Antiproliferative Evaluation
por: Sitong Wu, et al.
Publicado: (2021)

Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance
por: Shangwei Zhong, et al.
Publicado: (2021)

<i>AC016745.3</i> Regulates the Transcription of AR Target Genes by Antagonizing NONO
por: Yali Lu, et al.
Publicado: (2021)

Avances en el tratamiento de cáncer de próstata resistente a la castración: énfasis en nuevas terapias hormonales
por: Berlin,Alejandro, et al.
Publicado: (2015)

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
por: Archibald M, et al.
Publicado: (2016)

Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
por: Mateus Bringel Oliveira Duarte, et al.
Publicado: (2021)

IMMUNOHISTOCHEMICAL EXPRESSION OF ANDROGEN RECEPTOR IN TRIPLE NEGATIVE BREAST CARCINOMA AT ARMED FORCES INSTITUTE OF PATHOLOGY, RAWALPINDI
por: Amna Ameer, et al.
Publicado: (2021)

Association between Helicobacter pylori infection and mortality risk in prostate cancer patients receiving androgen deprivation therapy: A real‐world evidence study
por: Jui‐Ming Liu, et al.
Publicado: (2021)

Effect of Eight Weeks of Resistance Training and Consumption of Tribulus Terrestris on Androgenic Receptor-1, Fas Ligand Gene Expression, and Lipid Profiles in Rats Exposed to Stanozolol
por: Mohammad Derakhshandeh, et al.
Publicado: (2020)

IMMUNOHISTOCHEMICAL EXPRESSION OF ANDROGEN RECEPTOR IN TRIPLE NEGATIVE BREAST CARCINOMA AT ARMED FORCES INSTITUTE OF PATHOLOGY, RAWALPINDI
por: Amna Ameer, et al.
Publicado: (2021)

Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
por: Ieni A, et al.
Publicado: (2016)

Overcoming prostate cancer drug resistance with a novel organosilicon small molecule
por: Rui Zhao, et al.
Publicado: (2021)

Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller CJ, et al.
Publicado: (2012)

Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer
por: Tai Z, et al.
Publicado: (2020)

Prenatal Stress Up-Regulated Hippocampal Glucocorticoid Receptor Expression in Female Adult Rat Offspring
por: Liao,Libin, et al.
Publicado: (2020)

Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia
por: Bong Kyun Park, et al.
Publicado: (2019)

Association of the polymorphism in the androgen receptor gene and endothelial function in men with type 2 diabetes
por: Irina Alekseevna Khripun, et al.
Publicado: (2015)

Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy
por: Troncoso,Mayarling Francisca, et al.
Publicado: (2021)

Complete Androgen Insensitivity Syndrome: From the Relevance of an Accurate Genetic Diagnosis to the Challenge of Clinical Management. A Case Report
por: Federica Barbagallo, et al.
Publicado: (2021)

Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells
por: Tambe P, et al.
Publicado: (2018)

A Mansonone Derivative Coupled with Monoclonal Antibody 4D5-Modified Chitosan Inhibit AKR1C3 to Treat Castration-Resistant Prostate Cancer
por: Zhou M, et al.
Publicado: (2020)

Folic Acid–Modified miR-491-5p–Loaded ZIF-8 Nanoparticles Inhibit Castration-Resistant Prostate Cancer by Regulating the Expression of EPHX1
por: Guanqun Ju, et al.
Publicado: (2021)

Analyzing the Estrogen Receptor Status of Liver Metastases with [<sup>18</sup>F]-FES-PET in Patients with Breast Cancer
por: Jorianne Boers, et al.
Publicado: (2021)

Updates on Molecular and Biochemical Development and Progression of Prostate Cancer
por: Omar Fahmy, et al.
Publicado: (2021)

Para entender la acción de cortisol en inflamación aguda: una mirada desde la glándula suprarrenal hasta la célula blanco
por: Guerrero,Julia
Publicado: (2017)